Theravance Biopharma, Inc. (TBPH)
$17.04+$0.01 (+0.06%) Today
Theravance Biopharma Inc is a biopharmaceutical company focused on the development and commercialization of medicines to improve patients lives. The company leverages decades of expertise and has developed FDA-approved YUPELRI (revefenacin) inhalation solution for the maintenance treatment of patients with COPD. Its ampreloxetine Phase 3 clinical study (CYPRESS) for the treatment of symptomatic neurogenic orthostatic hypotension in patients with multiple system atrophy did not meet its primary endpoint. The company operates in a single segment, the development and commercialization of human therapeutics, and operates in the United States, which generates maximum revenue, and Europe.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 8 | 356,975 | $6.13M |
| Grant or award | 11 | 115,785 | |
| Tax withholding / forfeiture | 5 | 48,023 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
56 Form 4 filings on record, the earliest from Nov 13, 2024, newest first. Filing history page 1 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Rick E. Winningham - Officer | Tax withholding / forfeiture | Ordinary Shares | 20,034 | $16.95 | $340K | |
| Aziz Sawaf - Officer | Tax withholding / forfeiture | Ordinary Shares | 8,112 | $16.95 | $137K | |
| Aine Miller - Officer | Tax withholding / forfeiture | Ordinary Shares | 6,258 | $16.95 | $106K | |
| Brett A. Grimaud - Officer | Tax withholding / forfeiture | Ordinary Shares | 7,952 | $16.95 | $135K | |
| Rhonda Farnum - Officer | Tax withholding / forfeiture | Ordinary Shares | 5,667 | $16.95 | $96K | |
| Eli Samaha - 10% Owner | Open-market sale | COM | 1,400 | $17.04 | $24K | |
| Eli Samaha - 10% Owner | Open-market sale | COM | 5,564 | $17.17 | $96K | |
| Eli Samaha - 10% Owner | Open-market sale | COM | 273,871 | $17.23 | $4.72M | |
| Eli Samaha - 10% Owner | Open-market sale | COM | 25,027 | $17.13 | $429K | |
| Eli Samaha - 10% Owner | Open-market sale | COM | 37,799 | $17.00 | $643K | |
| Aine Miller - Officer | Grant or award | Ordinary Shares | 18,750 | $0.00 | - | |
| Rhonda Farnum - Officer | Open-market sale | Ordinary Shares | 3,329 | $16.39 | $55K | |
| Rhonda Farnum - Officer | Open-market sale | Ordinary Shares | 3,328 | $16.38 | $55K | |
| Rhonda Farnum - Officer | Open-market sale | Ordinary Shares | 6,657 | $16.39 | $109K | |
| Alsup Laurie Smaldone | Grant or award | Ordinary Shares | 6,009 | $0.00 | - | |
| Alsup Laurie Smaldone | Grant or award | Share Option (Right to Buy) | 13,398 | $0.00 | - | |
 Susannah Gray | Grant or award | Ordinary Shares | 6,009 | $0.00 | - | |
| Susannah Gray | Grant or award | Share Option (Right to Buy) | 13,398 | $0.00 | - | |
| Dean J. Mitchell | Grant or award | Share Option (Right to Buy) | 13,398 | $0.00 | - | |
| Dean J. Mitchell | Grant or award | Ordinary Shares | 6,009 | $0.00 | - | |
| Donal O'Connor | Grant or award | Ordinary Shares | 6,009 | $0.00 | - | |
| Donal O'Connor | Grant or award | Share Option (Right to Buy) | 13,398 | $0.00 | - | |
| Deepika Pakianathan | Grant or award | Share Option (Right to Buy) | 13,398 | $0.00 | - | |
| Deepika Pakianathan | Grant or award | Ordinary Shares | 6,009 | $0.00 | - | |
| Rick E. Winningham - Officer | Tax withholding / forfeiture | Ordinary Shares | 20,038 | $16.55 | $332K | |
| Aziz Sawaf - Officer | Tax withholding / forfeiture | Ordinary Shares | 8,670 | $16.55 | $143K | |
| Aine Miller - Officer | Tax withholding / forfeiture | Ordinary Shares | 6,827 | $16.55 | $113K | |
| Brett A. Grimaud - Officer | Tax withholding / forfeiture | Ordinary Shares | 8,829 | $16.55 | $146K | |
| Rhonda Farnum - Officer | Tax withholding / forfeiture | Ordinary Shares | 5,678 | $16.55 | $94K | |
| Rick E. Winningham - Officer | Grant or award | Ordinary Shares | 75,000 | $0.00 | - | |
| Aziz Sawaf - Officer | Grant or award | Ordinary Shares | 37,500 | $0.00 | - | |
| Brett A. Grimaud - Officer | Grant or award | Ordinary Shares | 37,500 | $0.00 | - | |
| Rhonda Farnum - Officer | Grant or award | Ordinary Shares | 18,750 | $0.00 | - | |
| Rhonda Farnum - Officer | Open-market sale | Ordinary Shares | 15,534 | $14.00 | $217K | |
| Rhonda Farnum - Officer | Open-market sale | Ordinary Shares | 7,767 | $13.92 | $108K | |
| Rhonda Farnum - Officer | Open-market sale | Ordinary Shares | 7,766 | $13.92 | $108K | |
| Rick E. Winningham - Officer | Tax withholding / forfeiture | Ordinary Shares | 74,975 | $19.66 | $1.47M | |
| Aziz Sawaf - Officer | Tax withholding / forfeiture | Ordinary Shares | 20,672 | $19.66 | $406K | |
| Aine Miller - Officer | Tax withholding / forfeiture | Ordinary Shares | 16,851 | $19.66 | $331K | |
| Brett A. Grimaud - Officer | Tax withholding / forfeiture | Ordinary Shares | 20,833 | $19.66 | $410K | |
| Rhonda Farnum - Officer | Tax withholding / forfeiture | Ordinary Shares | 13,929 | $19.66 | $274K | |
| Rhonda Farnum - Officer | Open-market sale | Ordinary Shares | 7,767 | $18.75 | $146K | |
| Rhonda Farnum - Officer | Open-market sale | Ordinary Shares | 7,766 | $18.75 | $146K | |
| Rhonda Farnum - Officer | Open-market sale | Ordinary Shares | 15,534 | $18.75 | $291K |
A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| - | - | - | - | View on EDGAR |
Theravance Biopharma, Inc. (TBPH) had 14 insider filings in the last 90 days, with the most recent on 2026-08-24. The full record for TBPH runs to 56 Form 4 filings, the earliest from 2024-11-13. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of TBPH were filed in the last 90 days.
8 insider sales of TBPH were filed in the last 90 days, totaling $6.13M.
This page tracks TBPH Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add TBPH to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
